Niklas Arkadiusz A, Flotyńska Anna, Zdrojewski Tomasz, Pająk Andrzej, Topór-Mądry Roman, Nadrowski Paweł, Polakowska Maria, Kwaśniewska Magdalena, Puch-Walczak Aleksandra, Bielecki Wojciech, Kozakiewicz Krystyna, Drygas Wojciech, Tykarski Andrzej
Department of Hypertension, Angiology and Internal Disease, Poznan University of Medical Science, ul.Dluga 1/2, 61-848 Poznan, Poland.
Cardiol J. 2018;25(3):333-344. doi: 10.5603/CJ.a2018.0043. Epub 2018 Apr 19.
The aim of this study was to assess changes in the prevalence, awareness, and treatment of hypertension and its effectiveness between 2007 (WOBASZ Senior study) and 2013-2014 (WOBASZ II) in a sample of the Polish population over the age of 75 years.
Sampling had three stages, stratified according to voivodeships, type of community, and gen-der. Finally, the WOBASZ II study included 467 persons (290 women and 177 men). For a comparison of the data, 1096 persons (538 women and 554 men) examined in the WOBASZ Senior study were used.
Systolic and diastolic blood pressures significantly decreased from 153.0 ± 23.9 mmHg to 142.9 ± 22.3 mmHg and from 85.2 ± 11.9 mmHg to 78.4 ± 11.3 mmHg, respectively, from 2007 to 2014 (p < 0.0001). Prevalence of hypertension among people included in WOBASZ studies slightly decreased from 83.8% to 77.9% (rate ratio [RR]: 0.95; 95% confidence interval [CI]: 0.78-1.16) in men, and from 75.4% to 71.8% (RR: 0.93; 95% CI: 0.8-1.09) in women. Hypertension awareness was improved from 59.2% to 72.9% (RR: 1.23; 95% CI: 0.97-1.56) in men, and from 74,8% to 93% (RR: 1.26; 95% CI: 1.01-1.58) in women. The proportion of men and women, with implemented hypertension treatment, increased from 48.4% to 61.1% (RR: 1.26; 95% CI: 1.01-1.58), and from 63.2% to 82.0% (RR: 1.3; 95% CI: 1.1-1.53), respectively. The effectiveness of the treatment was improved over two-fold, there was an increase from 10.3% to 26.8% (RR: 2.65; 95% CI: 1.81-3.89) in men, and from 13.8% to 33.5% in women (RR: 2.44; 95% CI: 1.81-3.3).
The prevalence of hypertension in Polish seniors remains high, but has decreased slightly in the perspective of the last 7 years. Although treatment and control has improved over the last decade, it remains below expectations. Efforts to improve the diagnosis and effective treatment of hypertension in Polish seniors should be intensified.
本研究旨在评估2007年(WOBASZ老年研究)至2013 - 2014年(WOBASZ II)期间,75岁以上波兰人群样本中高血压患病率、知晓率、治疗情况及其效果的变化。
抽样分三个阶段,根据省、社区类型和性别进行分层。最终,WOBASZ II研究纳入467人(290名女性和177名男性)。为比较数据,使用了在WOBASZ老年研究中检查的1096人(538名女性和554名男性)。
从2007年到2014年,收缩压和舒张压分别从153.0±23.9 mmHg显著降至142.9±22.3 mmHg,从85.2±11.9 mmHg降至78.4±11.3 mmHg(p < 0.0001)。WOBASZ研究纳入人群中,男性高血压患病率从83.8%略降至77.9%(率比[RR]:0.95;95%置信区间[CI]:0.78 - 1.16),女性从75.4%降至71.8%(RR:0.93;95% CI:0.8 - 1.09)。男性高血压知晓率从59.2%提高到72.9%(RR:1.23;95% CI:0.97 - 1.56),女性从74.8%提高到93%(RR:1.26;95% CI:1.01 - 1.58)。接受高血压治疗的男性和女性比例分别从48.4%增至61.1%(RR:1.26;95% CI:1.01 - 1.58)和从63.2%增至82.0%(RR:1.3;95% CI:1.1 - 1.53)。治疗效果提高了两倍多,男性从10.3%增至26.8%(RR:2.65;95% CI:1.81 - 3.89),女性从13.8%增至33.5%(RR:2.44;95% CI:1.81 - 3.3)。
波兰老年人高血压患病率仍然很高,但从过去7年来看略有下降。尽管过去十年治疗和控制情况有所改善,但仍低于预期。应加大力度改善波兰老年人高血压的诊断和有效治疗。